Hsbc Holdings PLC Oric Pharmaceuticals, Inc. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$2.41 - $5.89 $12,050 - $29,450
-5,000 Reduced 8.33%
55,000 $323,000
Q3 2022

Nov 14, 2022
BUY
$3.15 - $5.24 $78,750 - $131,000
25,000 Added 71.43%
60,000 $192,000
Q2 2022

Aug 11, 2022
BUY
$2.7 - $7.07 $94,500 - $247,450
35,000 New
35,000 $158,000

Others Institutions Holding ORIC

# of Institutions
124
Shares Held
66.6M
Call Options Held
7.8K
Put Options Held
700
View Full List

About Oric Pharmaceuticals, Inc.

ORIC Quotes by TradingView
  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $336M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email